Delivery Order SPE2DB25D9307-SPE2DB25FWQMR

This is a $18,371.82 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $2,705.58 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...

This is a $50,453.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,334,278 units of the prescription medication ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit organization. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of January 26, 2024 and a potential value of $3,173.45. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4563702288 ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $2,002.90 and a period of performance through February 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the sole awardee on...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a potential value of $15,255.89 and a completion date of December 22, 2023. The contract does not have a set-aside designation. Amerisourcebergen Drug Corporation, through its Corporate Office division,...

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ELIQUIS 5 MG TABLET 60S. The order has a completion date of February 27, 2024 and a potential value of $30,615.89. This delivery order is issued under an indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value up to $999,999,999.00 and a performance period through...

This federal contract award, with ID SPE2DB20D1100|SPE2DB25FY53L, is for the delivery of 4566108771 units of the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The award, made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, has a ceiling value of $12,781.81 and an ultimate completion date of October 16, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ELIQUIS 5 MG TABLET 60S. The delivery order, valued at $5,236.95, has a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $26,986.97 and a performance period through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...